| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48.7M | +0.1% | +20.6% |
| Cost of Revenue | $9.8M | -0.1% | +16.3% |
| Gross Profit | $38.8M | +0.1% | +21.8% |
| R&D Expense | $4.2M | -1.6% | +6.2% |
| SG&A Expense | $10.0M | -6.4% | +23.9% |
| Operating Income | -$5.4M | +23.1% | +29.5% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.5M | -22.4% | -12.4% |
| Accounts Receivable | $26.5M | +8.9% | +6.5% |
| Inventory | $35.7M | +4.3% | +40.0% |
| Current Assets | $210.8M | +1.6% | +3.5% |
| Total Assets | $234.3M | +1.5% | +3.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.4M | — | — |
| Capital Expenditures | $7.1M | — | — |
| Investing Cash Flow | -$8.9M | — | — |
| Financing Cash Flow | $2.3M | — | — |
| Free Cash Flow | -$9.5M | — | — |
| — |
| — |
| Net Income | -$4.6M | +25.8% | +30.6% |
| EPS (Basic) | -$0.11 | +21.4% | +31.3% |
| EPS (Diluted) | -$0.11 | +21.4% | +31.3% |
| $26.4M |
| +6.8% |
| +7.1% |
| Long-term Debt | $35.5M | +0.1% | -1.8% |
| Total Liabilities | $62.1M | +2.6% | +0.2% |
| Stockholders' Equity | $172.1M | +1.0% | +4.3% |